Nichols & Pratt Advisers LLP Novartis Ag Transaction History

Nichols & Pratt Advisers LLP

$1.45 Billion
Q4 2024

A detailed history of Nichols & Pratt Advisers LLP transactions in Novartis Ag stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 17,722 shares of NVS stock, worth $1.99 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

17,722

Previous 37,347 52.55%

Holding current value

$1.99 Million

Previous $4.3 Million 59.86%

% of portfolio

0.12%

Previous 0.29%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$96.78 - $117.18 $1.9 Million - $2.3 Million	-19,625 Reduced 52.55%	17,722 $1.72 Million
Q3 2024 Oct 25, 2024	SELL	$106.13 - $120.89 $48,289 - $55,004	-455 Reduced 1.2%	37,347 $4.3 Million
Q2 2024 Jul 25, 2024	SELL	$92.57 - $107.37 $508,579 - $589,890	-5,494 Reduced 12.69%	37,802 $4.02 Million
Q1 2024 Apr 29, 2024	SELL	$95.27 - $108.47 $252,179 - $287,120	-2,647 Reduced 5.76%	43,296 $4.19 Million
Q4 2023 Feb 07, 2024	SELL	$92.27 - $101.54 $490,968 - $540,294	-5,321 Reduced 10.38%	45,943 $4.64 Million
Q3 2023 Nov 09, 2023	SELL	$94.73 - $105.13 $943,984 - $1.05 Million	-9,965 Reduced 16.27%	51,264 $5.22 Million
Q2 2023 Aug 02, 2023	SELL	$92.52 - $104.91 $5.27 Million - $5.97 Million	-56,952 Reduced 48.19%	61,229 $6.18 Million
Q1 2023 May 03, 2023	SELL	$80.03 - $92.81 $3.17 Million - $3.67 Million	-39,587 Reduced 25.09%	118,181 $10.9 Million
Q4 2022 Feb 03, 2023	SELL	$75.55 - $92.52 $733,439 - $898,184	-9,708 Reduced 5.8%	157,768 $14.3 Million
Q3 2022 Nov 01, 2022	SELL	$74.61 - $87.26 $7.07 Million - $8.26 Million	-94,695 Reduced 36.12%	167,476 $12.7 Million
Q2 2022 Aug 04, 2022	SELL	$80.52 - $93.75 $1.66 Million - $1.94 Million	-20,665 Reduced 7.31%	262,171 $22.2 Million
Q1 2022 May 10, 2022	SELL	$80.11 - $90.62 $585,684 - $662,522	-7,311 Reduced 2.52%	282,836 $24.8 Million
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $683,826 - $756,155	-8,580 Reduced 2.87%	290,147 $25.4 Million
Q3 2021 Nov 01, 2021	SELL	$81.78 - $95.14 $1.28 Million - $1.49 Million	-15,649 Reduced 4.98%	298,727 $24.5 Million
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $121,466 - $134,163	-1,425 Reduced 0.45%	314,376 $28.7 Million
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $651,383 - $768,164	-7,801 Reduced 2.41%	315,801 $27 Million
Q4 2020 Feb 08, 2021	SELL	$78.07 - $94.43 $481,926 - $582,916	-6,173 Reduced 1.87%	323,602 $30.6 Million
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $706,568 - $782,782	-8,602 Reduced 2.54%	329,775 $28.7 Million
Q2 2020 Aug 10, 2020	SELL	$80.93 - $91.1 $254,767 - $286,782	-3,148 Reduced 0.92%	338,377 $29.6 Million
Q1 2020 Apr 24, 2020	BUY	$70.67 - $99.01 $131,799 - $184,653	1,865 Added 0.55%	341,525 $28.1 Million
Q4 2019 Feb 07, 2020	SELL	$84.35 - $95.37 $2.6 Million - $2.94 Million	-30,788 Reduced 8.31%	339,660 $32.2 Million
Q3 2019 Nov 07, 2019	SELL	$85.54 - $94.26 $2.49 Million - $2.75 Million	-29,139 Reduced 7.29%	370,448 $32.2 Million
Q2 2019 Aug 05, 2019	SELL	$75.4 - $92.8 $1.02 Million - $1.26 Million	-13,527 Reduced 3.27%	399,587 $36.5 Million
Q1 2019 Apr 30, 2019	SELL	$75.32 - $86.15 $60,255 - $68,920	-800 Reduced 0.19%	413,114 $39.7 Million
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $402,772 - $448,485	-5,468 Reduced 1.3%	413,914 $35.5 Million
Q3 2018 Nov 05, 2018	SELL	$66.94 - $77.43 $61,919 - $71,622	-925 Reduced 0.22%	419,382 $36.1 Million
Q2 2018 Jul 27, 2018	SELL	$64.91 - $73.36 $3,440 - $3,888	-53 Reduced 0.01%	420,307 $31.8 Million
Q1 2018 May 11, 2018	BUY	$70.39 - $84.15 $11,403 - $13,632	162 Added 0.04%	420,360 $33.9 Million
Q4 2017 Feb 09, 2018	BUY	$72.33 - $77.64 $81,371 - $87,345	1,125 Added 0.27%	420,198 $35.3 Million
Q3 2017 Nov 08, 2017	SELL	$74.14 - $77.27 $155,323 - $161,880	-2,095 Reduced 0.5%	419,073 $36 Million
Q2 2017 Aug 08, 2017	BUY	N/A	421,168	421,168 $35.2 Million

Others Institutions Holding NVS

# of Institutions

1,479

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $241B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

News

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.

Account

Nichols & Pratt Advisers LLP Novartis Ag Transaction History